Claudia Hirth-Dietrich
Inventor
Stats
- 22 US patents issued
- 40 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 22 US Patents Issued
- 40 US Applications Filed
- 276 Total Citation Count
- May 2, 2016 Most Recent Filing
- Jan 16, 1992 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Bayer Aktiengesellschaft | 1
4 1 1 4 1 2 | 1992
1993 1995 2001 2002 2003 2005 |
| BAYER PHARMACEUTICALS CORPORATION | 1
| 2004
|
| BAYER SCHERING PHARMA AKTIENGESELLSCHAFT | 3
1 5 1 | 2002
2003 2005 2008 |
| ADVERIO PHARMA GMBH | 1
| 2011
|
| BAYER INTELLECTUAL PROPERTY GMBH | 2
2 | 2008
2014 |
| BAYER HEALTHCARE AG | 2
| 2005
|
| BAYER HEALTHCARE LLC | 1
1 2 6 | 2006
2008 2012 2013 |
| AICURIS GMBH & CO. KG | 2
| 2001
|
| BAYER CORPORATION | 1
| 2002
|
Inventor Addresses
| Address | Duration |
|---|---|
| Berlin, DE | May 21, 15 - Jun 25, 15 |
| WUPPERTAL, DE | Oct 27, 11 - Oct 27, 11 |
| Wuppertal, DE | Jun 22, 93 - Jan 29, 19 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 30 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 6 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 10189856 | 2019 | Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) | 3 |
| 2018/0169,095 | 2018 | THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC) | 0 |
| 2015/0328,145 | 2015 | TOPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB | 0 |
| 2015/0174,096 | 2015 | TOPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING SUNITINIB | 6 |
| 2015/0164,790 | 2015 | Topical Ophthalmological Pharmaceutical Composition containing Axitinib | 7 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.